Interface Engineer III
Myriad Genetics2 days ago
Remote, United StatesSenior
Responsibilities
- Manage onboarding and continuing technical support for complex EMR integration projects.
- Assess new data sources and help estimate effort, refine scope, and identify requirements and tasks.
- Lead development, testing, and support for networking and interoperability solutions between Myriad and external clinics and providers.
- Administer, set up, maintain, and automate Mirth interfaces and data transformations.
- Act as a technical lead and advocate for implementation best practices and improvements.
- Investigate and troubleshoot production issues across multiple platforms.
- Train non-technical teammates and provide ongoing technical support.
- Create detailed project documentation for handoff to support teams.
- Navigate difficult client conversations using effective written and verbal communication.
Requirements
- Bachelor's degree required.
- Expert knowledge of HL7 V2.x and ability to interpret standards including HL7 v3, C-CDA, FHIR R4, IHE ITI, and EDI X12 Claims.
- Expertise with Mirth, including JavaScript or other common interface engines.
- Understanding of network protocols, connectivity types, and secure interoperability solution design.
- Intermediate SQL proficiency, including writing complex-join queries for querying and reporting.
- Software engineering fundamentals for web-based and cloud-based applications.
- Ability to investigate and troubleshoot production issues on multiple platforms.
- Exposure to ETL concepts and processes.
- U.S. citizenship or Green Card status required.
- Must live full-time in the United States.
- Active Advanced Mirth Certification preferred.
- Python and/or software development knowledge is a bonus.
Tech Stack
Categories
Solutions Engineering
About Myriad Genetics
Myriad Genetics develops and sells molecular diagnostic and genetic tests that assess disease risk, inform diagnosis, and guide treatment for clinicians and patients across oncology, women’s health, and mental health. Its portfolio includes hereditary cancer screening, prenatal carrier screening, tumor profiling, and pharmacogenomic tests, delivered through healthcare providers and payer-reimbursed lab services with EMR integrations. Founded in 1991 and headquartered in Salt Lake City, it is a public company listed on NASDAQ.